Pharmarise Holdings Corporation

TSE:2796 Stock Report

Market Cap: JP¥6.9b

Pharmarise Holdings Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Masayuki Akiyama

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.3yrs
CEO ownership0.4%
Management average tenureno data
Board average tenure6.3yrs

Recent management updates

Recent updates

Here's Why Pharmarise Holdings (TSE:2796) Has A Meaningful Debt Burden

Aug 13
Here's Why Pharmarise Holdings (TSE:2796) Has A Meaningful Debt Burden

Pharmarise Holdings' (TSE:2796) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 22
Pharmarise Holdings' (TSE:2796) Shareholders Will Receive A Bigger Dividend Than Last Year

Pharmarise Holdings (TSE:2796) Is Paying Out A Larger Dividend Than Last Year

Mar 07
Pharmarise Holdings (TSE:2796) Is Paying Out A Larger Dividend Than Last Year

CEO

Masayuki Akiyama (62 yo)

6.3yrs

Tenure

Mr. Masayuki Akiyama is a President, COO & Representative Director of Pharmarise Holdings Corporation since August 2018 and serves as its Chief Executive Officer. He served as Senior Managing Director of P...


Board Members

NamePositionTenureCompensationOwnership
Masayuki Akiyama
Presidentno datano data0.36%
¥ 25.1m
Keiko Matsuura
Senior MD & Director15.2yrsno data0.39%
¥ 27.1m
Toshimichi Ohno
Chairman of the Board40.4yrsno data29.45%
¥ 2.0b
Sayoko Ohno
Vice Chairman of the Board35.3yrsno data3.71%
¥ 257.1m
Makoto Miura
Auditorless than a yearno data0.075%
¥ 5.2m
Hiroshi Kanno
Director4.3yrsno data0.082%
¥ 5.7m
Norio Watanabe
Independent External Director9.3yrsno data0.024%
¥ 1.7m
Hiromu Tada
Independent External Director8.3yrsno datano data
Yutaka Numata
Director6.3yrsno data0.055%
¥ 3.8m
Ichijo Toda
Independent External Director4.3yrsno datano data
Tsuneo Sonobe
Outside Audit & Supervisory Board Member4.3yrsno datano data
Ai Aizawa
Directorless than a yearno datano data

6.3yrs

Average Tenure

71yo

Average Age

Experienced Board: 2796's board of directors are considered experienced (6.3 years average tenure).